Overview

Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Helicobacter pylori (H. pylori) infects more than 50% of the population in the world(1), especially 47-66% in China.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Treatments:
Amoxicillin
Esomeprazole
Tinidazole